Oncolytics Biotech Inc Net Asset Quality Index
Oncolytics Biotech Inc net asset quality index. Oncolytics Biotech Inc (ONC) has a Net Asset Quality Index of 30.5% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CA$19.97 Million minus total liabilities of CA$13.88 Million yields net assets of CA$6.09 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Oncolytics Biotech Inc net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Oncolytics Biotech Inc (1999–2024)
Net asset quality index of Oncolytics Biotech Inc from 1999 to 2024. This chart shows how Oncolytics Biotech Inc's Net Asset Quality Index has evolved across 26 annual periods from 1999 to 2024. As of June 2025, the index stands at 30.5%, representing net assets of CA$6.09 Million against total assets of CA$19.97 Million CAD. Check ONC strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Oncolytics Biotech Inc Net Asset Quality Index by Year (1999–2024)
Oncolytics Biotech Inc net asset quality index by year from 1999 to 2024. The table below presents the year-by-year Net Asset Quality Index for Oncolytics Biotech Inc from 1999 to 2024, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ONC market cap overview.
| Year | Quality Index | Net Assets (CAD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 29.6% | CA$5.98 Million | CA$20.19 Million | CA$14.20 Million | ▼ -41.4 pp |
| 2023 | 71.0% | CA$27.56 Million | CA$38.82 Million | CA$11.26 Million | ▲ +0.0 pp |
| 2022 | 71.0% | CA$26.50 Million | CA$37.33 Million | CA$10.83 Million | ▼ -7.7 pp |
| 2021 | 78.7% | CA$36.10 Million | CA$45.88 Million | CA$9.78 Million | ▲ +6.6 pp |
| 2020 | 72.1% | CA$24.75 Million | CA$34.35 Million | CA$9.59 Million | ▲ +72.6 pp |
| 2019 | -0.5% | CA$-107.89K | CA$19.66 Million | CA$19.77 Million | ▼ -42.2 pp |
| 2018 | 41.7% | CA$6.20 Million | CA$14.87 Million | CA$8.67 Million | ▼ -4.0 pp |
| 2017 | 45.6% | CA$8.28 Million | CA$18.15 Million | CA$9.87 Million | ▼ -26.8 pp |
| 2016 | 72.4% | CA$10.69 Million | CA$14.76 Million | CA$4.07 Million | ▼ -17.7 pp |
| 2015 | 90.1% | CA$24.67 Million | CA$27.38 Million | CA$2.71 Million | ▲ +9.7 pp |
| 2014 | 80.4% | CA$13.82 Million | CA$17.19 Million | CA$3.37 Million | ▲ +1.7 pp |
| 2013 | 78.7% | CA$22.21 Million | CA$28.22 Million | CA$6.01 Million | ▲ +11.7 pp |
| 2012 | 67.0% | CA$14.79 Million | CA$22.08 Million | CA$7.29 Million | ▼ -15.0 pp |
| 2011 | 81.9% | CA$29.52 Million | CA$36.02 Million | CA$6.50 Million | ▼ -12.4 pp |
| 2010 | 94.4% | CA$41.93 Million | CA$44.43 Million | CA$2.50 Million | ▲ +6.2 pp |
| 2009 | 88.1% | CA$32.84 Million | CA$37.27 Million | CA$4.43 Million | ▲ +20.5 pp |
| 2008 | 67.6% | CA$9.45 Million | CA$13.99 Million | CA$4.53 Million | ▼ -23.3 pp |
| 2007 | 90.8% | CA$27.96 Million | CA$30.78 Million | CA$2.82 Million | ▼ -0.9 pp |
| 2006 | 91.8% | CA$30.80 Million | CA$33.57 Million | CA$2.77 Million | ▼ -4.3 pp |
| 2005 | 96.0% | CA$44.45 Million | CA$46.29 Million | CA$1.84 Million | ▼ -1.2 pp |
| 2004 | 97.2% | CA$38.39 Million | CA$39.49 Million | CA$1.10 Million | ▲ +1.2 pp |
| 2003 | 96.0% | CA$25.02 Million | CA$26.05 Million | CA$1.03 Million | ▲ +3.9 pp |
| 2002 | 92.2% | CA$16.56 Million | CA$17.97 Million | CA$1.41 Million | ▲ +8.5 pp |
| 2001 | 83.6% | CA$15.95 Million | CA$19.07 Million | CA$3.12 Million | ▼ -8.3 pp |
| 2000 | 92.0% | CA$19.92 Million | CA$21.66 Million | CA$1.74 Million | ▼ -4.8 pp |
| 1999 | 96.7% | CA$6.93 Million | CA$7.16 Million | CA$236.10K | — |